Thread by @Be_and_Make

In large cap space, CadilaHC looks very interesting.
Generally i restrict to micro caps but new opportunity size looks very interesting which is coupled with existing business.
Stock at all time highs but valuations looks still attractive.
@soicfinance @unseenvalue @KevalAshar

Zydu Cadila's new drug *'Virafin',* which is considered successful in the treatment of Covid patients, will soon be available in three districts of UttarPradesh, namely Lucknow, Varanasi and Prayagraj.
#CADILAHC

CADILA: MAHARASHTRA MINISTER: ALSO EYEING PURCHASE OF ZYDUS CADILA, J&J VACCINES GOING AHEAD

#CADILAHC

@sandipsabharwal @soicfinance @daytradertelugu @Moneypurseadv @IKSmallcaps @sandeepraop1 @PrasadWakchaure @KevalAshar @Ayush_Gupta03 @AimInvestments

ViraFin seems to be a most effective drug for covid-19.
Single dose injection gives wonderful results in test trails.
Demand of Remdesivir is going to reduce if Virafin comes out to market.

Zydus Cadila likely to seek approval for its COVID-19 vaccine this month.

Zydus Cadila is planning to produce 10 million doses per month of its COVID-19 vaccine, to begin with, and subsequently raise it to 20 million doses.

#zyduscadila
#CADILAHC

@soicfinance @KevalAshar @nishkumar1977 @unseenvalue @ZydusUniverse @sandipsabharwal @sandeepraop1

#CadilaHealthCare #zyduscadila